Robert Califf, the commissioner of the US Food and Drug Administration, is concerned that a laser focus on ensuring diversity in clinical trials is a sideshow from the real problem: “lack of equity in our health care system.”
Speaking at a 12 July fireside chat sponsored by the Alliance for a Stronger FDA, the agency head said that...